Therma Bright Enhances Balance and Seeks FDA Insight
Company Announcements

Therma Bright Enhances Balance and Seeks FDA Insight

Story Highlights

Therma Bright (TSE:THRM) has released an update.

Therma Bright Inc. has initiated a shares for debt transaction with AI4LYF to manage its obligations and preserve cash, while also seeking FDA classification for their AI-powered cough monitoring technology. Furthermore, the company is enhancing investor relations by engaging WIRED IR LLC for marketing services, with a flexible budget starting at $25,000 per week.

For further insights into TSE:THRM stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskTherma Bright Inc. Strengthens Advisory Board
TipRanks Canadian Auto-Generated NewsdeskTherma Bright Applauds Partner’s Prestigious RDD Award
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App